NASDAQ: RGEN
Repligen Corp Stock Ownership - Who owns Repligen?

Insider buying vs selling

Have Repligen Corp insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Anthony HuntDirector2024-12-0511,808$33.87
$399.94kBuy
Anthony HuntDirector2024-11-2124,246$33.87
$821.21kBuy
Anthony HuntDirector2024-11-2124,246$139.67
$3.39MSell
Jason K. GarlandCFO2024-11-20367$123.41
$45.29kSell
Olivier LoeillotChief Executive Officer2024-11-20861$123.41
$106.26kSell
Glenn P. MuirDirector2024-11-1919,000$36.29
$689.51kBuy
Anthony HuntDirector2024-09-101,495$143.77
$214.94kSell
Anthony HuntDirector2024-09-109,369$144.88
$1.36MSell
Anthony HuntDirector2024-09-1010,723$145.95
$1.57MSell
Anthony HuntDirector2024-09-10604$146.67
$88.59kSell

1 of 6

RGEN insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RGEN insiders and whales buy or sell their stock.

RGEN Shareholders

What type of owners hold Repligen Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bvf Partners L P19.74%11,060,200$1.77BInsider
Roy T. Eddleman13.72%7,685,810$1.23BInsider
Blackrock Inc 112.69%7,107,557$1.14BInstitution
Blackrock Inc12.69%7,107,557$1.14BInstitution
Price T Rowe Associates Inc11.41%6,392,239$1.02BInstitution
Vanguard Group Inc9.00%5,044,367$807.20MInstitution
State Street Corp2.90%1,623,683$259.82MInstitution
Champlain Investment Partners LLC2.54%1,420,935$227.38MInstitution
Sands Capital Management LLC2.53%1,419,063$227.08MInstitution
Bank Of New York Mellon Corp2.43%1,363,951$218.26MInstitution

1 of 3

RGEN vs Medical Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RGEN72.44%27.56%Net SellingNet Buying
TFX95.94%2.76%Net Selling
ATR89.02%3.65%Net SellingNet Selling
STVN17.87%0.00%
MMSI95.00%5.00%Net SellingNet Buying

Repligen Stock Ownership FAQ

Who owns Repligen?

Repligen (NASDAQ: RGEN) is owned by 98.81% institutional shareholders, 37.59% Repligen insiders, and 0.00% retail investors. Bvf Partners L P is the largest individual Repligen shareholder, owning 11.06M shares representing 19.74% of the company. Bvf Partners L P's Repligen shares are currently valued at $1.79B.

If you're new to stock investing, here's how to buy Repligen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.